Oncternal Therapeutics, Inc. posts $0 million annual profit

Oncternal Therapeutics, Inc. [ONCT]  has posted annual profit of $0 million for the year ended Dec 31,2022.

The company based in California(CA)reported a fellin revenue to $0 milion for the year when compared to $4.32 million in the previous year.

A filing from the company with the Securities and Exchange Commission on Mar 9,2023 showed that its revenue is  up 100.00% year-over-year.

The company reported basic earnings per share of $0 and diluted earnings per share of $0.

Oncternal Therapeutics, Inc. operates in the Pharmaceutical Preparations sector.